Harim Tavares dos Santos

Dr. Harim Tavares dos Santos

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2023 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
LSLucas Lacerda de Souza
Lucas Lacerda de Souza
FFFelipe Paiva Fonseca
Felipe Paiva Fonseca
Anna Luíza Damaceno AraújoAnna Luíza Damaceno Araújo
Anna Luíza Damaceno Araújo
MLMárcio Ajudarte Lopes
Márcio Ajudarte Lopes
Pablo VargasPablo Vargas
Pablo Vargas
Alan Roger Santos-SilvaAlan Roger Santos-Silva
Alan Roger Santos-Silva

9 December 2020 in Cells
Verified
Journal Article
Open access
PDF file
HSHarim Tavares dos Santos
Harim Tavares dos Santos
KKKyungsook Kim
Kyungsook Kim
TOTeruo Okano
Teruo Okano
JCJean M. Camden
Jean M. Camden
GWGary A. Weisman
Gary A. Weisman
Kihoon NamKihoon Nam
Kihoon Nam
Thermoresponsive cell culture plates release cells as confluent living sheets in response to small changes in temperature, with recovered cell sheets retaining functional extracellular matrix proteins and tight junctions, both of which indicate formation of intact and functional tissue. Our recent studies demonstrated that cell sheets are highly effective in promoting mouse submandibular gland (SMG) cell differentiation and recovering tissue integrity. However, these studies were performed only at early time points and extension of the observation period is needed to investigate duration of the cell sheets. Thus, the goal of this study was to demonstrate that treatment of wounded mouse SMG with cell sheets is capable of increasing salivary epithelial integrity over extended time periods. The results indicate that cell sheets promote tissue organization as early as eight days after transplantation and that these effects endure through Day 20. Furthermore, cell sheet transplantation in wounded SMG induces a significant time-dependent enhancement of cell polarization, differentiation and ion transporter expression. Finally, this treatment restored saliva quantity to pre-wounding levels at both eight and twenty days post-surgery and significantly improved saliva quality at twenty days post-surgery. These data indicate that cell sheets engineered with thermoresponsive cell culture plates are useful for salivary gland regeneration and provide evidence for the long-term stability of cell sheets, thereby offering a potential new therapeutic strategy for treating hyposalivation.

17 November 2022 in JADA Foundational Science
Verified
Journal Article
Open access
HSHarim Tavares dos Santos
Harim Tavares dos Santos
FMFrank Maslow
Frank Maslow
Kihoon NamKihoon Nam
Kihoon Nam
BTBryan Trump
Bryan Trump
GWGary A. Weisman
Gary A. Weisman
Olga BakerOlga Baker
Olga Baker
Sjögren syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration and diminished secretory function of the salivary glands. Dexamethasone (DEX) resolves dry mouth and lymphocytic infiltration; however, this treatment is difficult to maintain because of multiple adverse effects (eg, osteoporosis and skin thinning); likewise, aspirin-triggered resolvin D1 (AT-RvD1) increases saliva secretion but cannot eliminate lymphocytic infiltration. Previous studies showed that a combination of low-dose DEX with AT-RvD1 before disease onset prevents SS-like features in a mouse model; however, this is not clinically practical because there are no reliable indicators of SS before disease onset. Therefore, the authors applied the combined treatment at disease onset to show its efficacy and comparative lack of adverse effects, so that it may reasonably be maintained over a patient’s lifetime. NOD/ShiLtJ mice were treated with ethanol (vehicle control), high-dose DEX alone, AT-RvD1 alone, or a combination of low-dose DEX with AT-RvD1 at disease onset for 8 weeks. Then saliva flow rates were measured, and submandibular glands were harvested for histologic analyses. A combined treatment of low-dose DEX with AT-RvD1 significantly decreased mast cell degranulation and lymphocytic infiltration, increased saliva secretion, and restored apical aquaporin-5 expression in submandibular glands of NOD/ShiLtJ mice. Low-dose DEX combined with AT-RvD1 reduces the severity of SS-like manifestation and prevents the development of advanced and potentially irreversible damage, all in a form that can reasonably be administered indefinitely without the need to cease treatment because of secondary effects.